The standout finding is LEG's 5.8% decline over three months compared with a 15.4% fall in the S&P, demonstrating that the stock has outperformed the benchmark by nearly 10 percentage points during a period of heightened volatility—a signal that its business model may provide downside protection in turbulent markets.
The primary risk is LEG's sustained negative multi‑year total return—averaging -26% annually over five years—which quantifies a substantial erosion of capital that could be exacerbated if its core markets (e.g., automotive seating) face prolonged demand shocks; investors must monitor macro trends and potential margin compression that could further depress share price.
The combination of a high RSI (65.8) and a modest Sharpe ratio (0.2) creates a divergence: smart money may be buying on fundamentals, but the price is nearing technical overextension, raising the risk of a short‑term correction that could test institutional patience.
The consistent double‑digit revenue decline across three years is the most concerning growth signal, as it erodes market share in core segments and reduces the base from which any margin improvements can be leveraged.
The sub‑20% gross margin exposes LEG to raw‑material price spikes; a 5% increase in material costs would cut gross profit by roughly $200 m (≈$0.05 per share), pressuring already thin operating margins and potentially triggering earnings shortfalls.
The 30% contraction in net profit margin is the dominant driver of ROE decline, underscoring a fundamental earnings weakness that cannot be offset by higher financial leverage alone.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 23.0 | 5.8 | 1.15 | 3.46 | 8.9 | 8.9 | 6.7 |
| 2024 | -74.2 | -11.7 | 1.20 | 5.31 | 8.1 | 7.8 | -14.0 |
| 2023 | -10.3 | -2.9 | 1.02 | 3.48 | 9.8 | 9.5 | -3.0 |
| 2022 | 18.9 | 6.0 | 0.99 | 3.16 | 11.7 | 11.4 | 6.0 |
| 2021 | 24.4 | 7.9 | 0.96 | 3.22 | 13.8 | 13.8 | 7.6 |
| 2020 | 18.2 | 5.9 | 0.90 | 3.42 | 11.1 | 11.1 | 5.3 |
| 2019 | 23.9 | 6.6 | 0.99 | 3.67 | 13.0 | 12.6 | 6.5 |
| 2018 | 26.4 | 7.2 | 1.26 | 2.92 | 18.1 | 17.3 | 9.0 |
| 2017 | 24.6 | 7.4 | 1.12 | 2.95 | 18.3 | 17.4 | 8.3 |
| 2016 | 35.3 | 10.3 | 1.26 | 2.73 | 21.0 | 19.7 | 12.9 |
| 2015 | 29.6 | 8.3 | 1.32 | 2.70 | 22.6 | 21.4 | 11.0 |
The 60‑day cash conversion cycle ties up approximately $150 million of net working capital (based on quarterly sales), limiting liquidity and increasing sensitivity to any slowdown in receivables or inventory turnover.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 318 | 68 | 43 | 72 | 51 | 60 |
| 2024 | 305 | 73 | 47 | 76 | 50 | 69 |
| 2023 | 358 | 77 | 49 | 76 | 51 | 76 |
| 2022 | 368 | 79 | 48 | 69 | 45 | 82 |
| 2021 | 382 | 90 | 47 | 70 | 56 | 81 |
| 2020 | 405 | 70 | 48 | 81 | 60 | 58 |
| 2019 | 370 | 62 | 45 | 76 | 45 | 62 |
| 2018 | 289 | 68 | 49 | 62 | 50 | 67 |
| 2017 | 326 | 68 | 55 | 61 | 51 | 72 |
| 2016 | 290 | 67 | 47 | 55 | 45 | 69 |
| 2015 | 277 | 62 | 48 | 50 | 37 | 73 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $3536M | $2514M | $1023M | $1656M | $1068M | $587M | $1744M | $775M |
| 2024 | $3662M | $2971M | $689M | $2049M | $1698M | $350M | $1690M | $846M |
| 2023 | $4634M | $3300M | $1333M | $2195M | $1830M | $366M | $1881M | $1263M |
| 2022 | $5186M | $3545M | $1641M | $2287M | $1970M | $316M | $1958M | $968M |
| 2021 | $5307M | $3659M | $1649M | $2288M | $1926M | $362M | $2065M | $1336M |
| 2020 | $4754M | $3364M | $1390M | $2065M | $1716M | $349M | $1612M | $1006M |
| 2019 | $4816M | $3504M | $1312M | $2278M | $2031M | $248M | $1538M | $928M |
| 2018 | $3382M | $2224M | $1158M | $1169M | $901M | $268M | $1525M | $816M |
| 2017 | $3518M | $2327M | $1191M | $1252M | $726M | $526M | $1734M | $943M |
| 2016 | $2984M | $1890M | $1094M | $960M | $678M | $282M | $1325M | $707M |
| 2015 | $2968M | $1870M | $1098M | $949M | $696M | $253M | $1311M | $701M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $338M | $293M | $-413M | $-57M | $281M | $-2M | $-27M |
| 2024 | $306M | $-37M | $-270M | $-82M | $224M | $-5M | $-136M |
| 2023 | $497M | $-91M | $-359M | $-114M | $383M | $-6M | $-239M |
| 2022 | $441M | $-181M | $-286M | $-100M | $341M | $-60M | $-229M |
| 2021 | $271M | $-226M | $-33M | $-107M | $165M | $-10M | $-218M |
| 2020 | $603M | $-49M | $-462M | $-66M | $536M | $-11M | $-212M |
| 2019 | $668M | $-1418M | $731M | $-143M | $525M | $-16M | $-205M |
| 2018 | $440M | $-264M | $-387M | $-160M | $281M | $-112M | $-194M |
| 2017 | $444M | $-153M | $-46M | $-159M | $284M | $-158M | $-186M |
| 2016 | $553M | $-67M | $-456M | $-124M | $429M | $-198M | $-177M |
| 2015 | $359M | $-63M | $-358M | $-103M | $256M | $-192M | $-172M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net